Peter Reynolds
Director of Finance/CFO at AEON Biopharma Sub, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Palmisano | M | 79 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Eric Carter | M | 72 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Shelley Thunen | F | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Chad Oh | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 years |
| Richard Taketa | M | 52 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 6 years |
| Melinda Day | F | 64 |
Boy Scouts of America (Orange County Council)
 Boy Scouts of America (Orange County Council) Services to the Health IndustryHealth Services Part of Boy Scouts of America, Boy Scouts of America (Orange County Council) provides support services to youth and families. The company is based in Santa Ana, CA. | 13 years |
| Chris Carr | M | 54 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 years |
| Darren O Brien | M | 48 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Vikram Malik | M | 61 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 10 years |
| Terry Scot Adams | M | 63 |
Boy Scouts of America (Orange County Council)
Boy Scouts of America (Orange County Council) Services to the Health IndustryHealth Services Part of Boy Scouts of America, Boy Scouts of America (Orange County Council) provides support services to youth and families. The company is based in Santa Ana, CA. | - |
| William Lyon | M | 50 |
Boy Scouts of America (Orange County Council)
Boy Scouts of America (Orange County Council) Services to the Health IndustryHealth Services Part of Boy Scouts of America, Boy Scouts of America (Orange County Council) provides support services to youth and families. The company is based in Santa Ana, CA. | - |
| Wayne J. Stelmar | M | 69 |
Boy Scouts of America (Orange County Council)
Boy Scouts of America (Orange County Council) Services to the Health IndustryHealth Services Part of Boy Scouts of America, Boy Scouts of America (Orange County Council) provides support services to youth and families. The company is based in Santa Ana, CA. | - |
| Adelbert L. Stagg | M | 77 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 years |
| Debra Morris | F | 65 | 11 years | |
| Simone Blank | F | 61 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Jost Fischer | M | 69 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 7 years |
| Ed Inal | M | - |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Starck | M | 57 | 11 years | |
| Mahvash Yazdi | F | 73 | 2 years | |
| Jeff Ingram | M | - | - | |
| Mike Ruberio | M | - | 7 years | |
| Jack Baikie | M | - | - | |
| Mark Litkovitz | M | - | 14 years | |
| Douglas E. Rutledge | M | - | - | |
| Dan Kelly | M | - | - | |
| James G. Gallas | M | - | - | |
| Patrick J. Bourke | M | - | - | |
| Bradley R. Kreick | M | - | - | |
| Howard Derman | M | - | - | |
| Terry Bayer | F | 74 | 2 years | |
| I. T. Corley | M | 79 | 5 years | |
| Mike Zafirovski | M | 70 | 11 years | |
| Vicente J. Anido | M | 71 | 6 years | |
| Philip Lochner | M | 80 | 10 years | |
| Richard Koppes | M | 77 | 10 years | |
| Lawrence M. Higby | M | 78 | 11 years | |
| David L. Goldsmith | M | 75 | 21 years | |
| Harriet B. Albery | F | - | 1 years | |
| Chris Karkenny | M | 55 | 6 years | |
| Daniel E. Greenleaf | M | 59 | 2 years | |
| Deb Crimmins | F | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 41 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Reynolds
- Personal Network
